- Hamilelik Kategorisi:B (FDA'ya göre)
Risk Summary:
- There are no adequate and well-controlled studies of infliximab in pregnant women. Animal studies have shown no evidence of harm to the fetus.
- The decision to use infliximab during pregnancy should be made in consultation with the patient's physician.
Klinik Hususlar:
- Yalnızca açıkça gerektiğinde kullanın.
- Consider discontinuing infliximab in pregnancy if there is no improvement in symptoms.
Animal Studies:
- Teratogenicity:No evidence of harm to the fetus was observed in animal studies.
_This information is not intended as a substitute for the expertise and advice of a healthcare provider. Always consult with your healthcare provider before taking any medication during pregnancy or while breastfeeding._